Duble Lumen Intubation

Sponsor
Lazarski University (Other)
Overall Status
Completed
CT.gov ID
NCT03624439
Collaborator
(none)
47
1
2
10.7
4.4

Study Details

Study Description

Brief Summary

Intrabronal intubation is one of the basic methods of airway protection during cardiac surgery. The use of double-lumen tubes in the implementation of a standard method based on macintosh laryngoscope may cause the prolongation of the procedure especially in the case of difficult airways. The aim of the study was to match the effectiveness of endotracheal intubation using a standard Macontosh laryngskop and a normal double-lumen tube versus the ETView DL tube.

Condition or Disease Intervention/Treatment Phase
  • Device: Standard double-lumen tube
  • Device: Double-Lumen Tube Vivasight-DL
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
47 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Double-Lumen Tube Vivasight-DL vs. Standard Duble-lumen Tube in Normal and Difficult Airway Scenarios: A Prospective, Randomized, Crossover, Simulation Trial
Actual Study Start Date :
Aug 7, 2018
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Normal airway

normal airway. the language has not been inflated. the instructor assessed the difficulty of intubation based on the Cormack - Lehane scale to the first degree

Device: Standard double-lumen tube
intubation using standard double-lumen tube with Macintosh laryngoscope

Device: Double-Lumen Tube Vivasight-DL
intubation using Double-Lumen Video Tube Vivasight-DL with Macintosh laryngoscope

Experimental: Difficult airway

dofficult airway. Difficult airways were obtained by means of language inflation using a simulator control panel, so as to obtain the degree of intubation difficulty assessed by an independent anesthesiologist to the third degree according to the Cormack-Lehane scale

Device: Standard double-lumen tube
intubation using standard double-lumen tube with Macintosh laryngoscope

Device: Double-Lumen Tube Vivasight-DL
intubation using Double-Lumen Video Tube Vivasight-DL with Macintosh laryngoscope

Outcome Measures

Primary Outcome Measures

  1. intubation time [1 day]

    from taking of the intubation device to successful intubation

Secondary Outcome Measures

  1. time to visualize the glottis [1 day]

    time defined as the time from taking laryngoscope in hand until you obtain visualize the glottis

  2. success of the first intubation trial [1 day]

    effectiveness of the first attempt of intubation by participants using four intubation devices

  3. overall success rate [1 day]

    effectiveness measured during a maximum of three intubation attempts, confirmed by a single lung ventilation test

  4. the degree of visibility of the glottis [1 day]

    The POGO score describes how much glottic opening is visible. A POGO score of 100% indicates visualization of the entire glottic opening from the anterior commissure of the vocal cords to the interarytenoid notch. A POGO score of 0% corresponds with no visualization of laryngeal structures.

  5. Cormack - Lehane grade [1 day]

    self-reported percentage the vocal cord visualization using the Cormack-Lehane grading (grade 1-4)

  6. ease of use [1 day]

    To access subjective opinions about the difficulty of the each intubation method, participants were asked to give a rating on a visual analogue scale (VAS) with a score from 1 (extremely easy) to 100 (extremely difficult).

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • anesthesiologist or a person in the course of specialization

  • consent voluntary participation in the study

Exclusion Criteria:
  • refusal to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Medicine, Lazarski University Warsaw Masovian Poland 02-662

Sponsors and Collaborators

  • Lazarski University

Investigators

  • Principal Investigator: Lukasz Szarpak, PhD, Lazarski University
  • Principal Investigator: Jacek Smereka, Phd, Wroclaw Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Łukasz Szarpak, Associate Professor, Lazarski University
ClinicalTrials.gov Identifier:
NCT03624439
Other Study ID Numbers:
  • ETI_2018_DL1
First Posted:
Aug 10, 2018
Last Update Posted:
Jul 31, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Łukasz Szarpak, Associate Professor, Lazarski University

Study Results

No Results Posted as of Jul 31, 2019